MAP — Microba Life Sciences Balance Sheet
0.000.00%
- AU$24.16m
- AU$20.32m
- AU$14.76m
Annual balance sheet for Microba Life Sciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | R2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | — | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 26.4 | 31.1 | 21.1 | 10.9 | 7.95 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.42 | 7.24 | 8.1 | 4.11 | 3.21 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 35.8 | 41.5 | 32.2 | 19 | 13.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.81 | 2.58 | 3.91 | 3.87 | 2.32 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 39.5 | 47 | 58.7 | 47.4 | 39.8 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.26 | 7.82 | 12.4 | 10.2 | 11.2 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.94 | 8.38 | 17.5 | 14.9 | 15.4 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 33.5 | 38.6 | 41.2 | 32.5 | 24.4 |
| Total Liabilities & Shareholders' Equity | 39.5 | 47 | 58.7 | 47.4 | 39.8 |
| Total Common Shares Outstanding |